GSK_ Annual_Report_2021-22

133 Notes to the Standalone Financial Statements for the year ended March 31, 2022 Note 12 : Trade receivables ( ` in lakhs) As at March 31, 2022 As at March 31, 2021 Unsecured, Considered good 205,23.89 215,60.46 Receivables which have significant increase in Credit Risk (Refer Note 50 C) 20,23.24 20,07.07 Less : Allowance for doubtful receivables (20,23.24) (20,07.07) 205,23.89 215,60.46 During the year ended March 31, 2022 the Company has created additional allowance for doubtful debts of ` 16.17 lakhs (net) (Previous Year: ` 2,06.05 lakhs (net)) . Trade Receivables Ageing :- ( ` in lakhs) Outstanding as at March 31, 2022 Not due Less than 6 months 6 months - 1 year 1-2 years 2-3 years More than 3 years Total (i) Undisputed trade receivables - considered good 191,74.74 7,55.10 88.71 99.79 2,17.77 1,87.78 205,23.89 (ii) Undisputed trade receivables - which have significant increase in credit risk 6.39 45.15 50.62 1.20 2,17.68 13,14.59 16,35.63 (iii) Disputed trade receivables - which have significant increase in credit risk - - 43.23 10.68 33.76 2,99.94 3,87.61 Less : Allowance for doubtful receivables (20,23.24) Total 205,23.89 ( ` in lakhs) Outstanding as at March 31, 2021 Not due Less than 6 months 6 months - 1 year 1-2 years 2-3 years More than 3 years Total (i) Undisputed trade receivables - considered good 142,06.26 68,04.49 64.86 4,40.71 44.14 - 215,60.46 (ii) Undisputed trade receivables - which have significant increase in credit risk 5.01 61.26 29.77 1,23.21 97.92 13,54.05 16,71.22 (iii) Disputed trade receivables - which have significant increase in credit risk - - 2.16 33.75 53.37 2,46.57 3,35.85 Less : Allowance for doubtful receivables (20,07.07) Total 215,60.46 Note 13 : Cash and cash equivalents ( ` in lakhs) As at March 31, 2022 As at March 31, 2021 Balances with Banks: Current account 50,73.12 205,83.20 Term deposits with original maturity period of less than three months 230,06.00 199,07.00 280,79.12 404,90.20